Flexion Therapeutics
FLXN
#7310
Rank
ยฃ0.34 B
Marketcap
ยฃ6.84
Share price
0.00%
Change (1 day)
7,834.83%
Change (1 year)

Revenue for Flexion Therapeutics (FLXN)

Revenue in 2021 (TTM): ยฃ73.34 Million

According to Flexion Therapeutics 's latest financial reports the company's current revenue is ยฃ75.3 Million. In 2020 the company made a revenue of ยฃ64.17 Million an increase over the revenue in the year 2019 that were of ยฃ54.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Flexion Therapeutics from 2018 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ73.34 M14.29%
2020ยฃ64.17 M17.26%
2019ยฃ54.72 M223.91%
2018ยฃ16.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Cara Therapeutics
CARA
ยฃ5.35 M-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
ยฃ56.52 M-24.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 91,681.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 B 62,435.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
ยฃ0.48 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
ยฃ0.53 B 613.94%๐Ÿ‡บ๐Ÿ‡ธ USA